May 22, 2026
avatar-torie-bosch
First Opinion editor

This week, the First Opinion that has most stuck with me is Krutika Kuppalli’s essay on her personal experience with Ebola: first as a physician helping to run an Ebola Treatment Unit in Sierra Leone in 2014, then, upon her return to the U.S., as a possible patient. She eventually tested negative for Ebola, but not before getting a sense of what her patients had experienced. “When we arrived at the hospital near midnight sirens blaring, another group of health workers in [personal protective equipment] was waiting,” she writes. “I remember the wheelchair coming toward me and the dozens of people staring as I was rushed into the isolation unit. In that moment, I no longer felt like a physician or a person — I felt like a threat.”

What’s most important about this piece is not Krutika’s own story, though that is deeply compelling. It’s that she uses her experience to remind us that stories about Ebola often overlook the experiences of Africans: the health care workers, the patients, their families.

She writes about “the disorientation of returning to a country that mobilized enormous resources around my single suspected case. Meanwhile, the people I had just left behind — hundreds of patients and dozens of local health care workers — received only a fraction of that attention and care.”

It’s something I hope to keep in mind as the Ebola outbreak, inevitably, continues.

Recommendation of the week: The other day, I revisited one of my all-time favorite longform articles: a 2005 feature about two young Amish men, unrelated but both named Abner Stoltzfus, who ended up dealing cocaine while working with the Pagans motorcycle gang. It’s just as good as I remembered.



Vegetable oil isn't the problem. The food product often surrounding the oil is, the writer contends.
Adobe

The seed oil panic is hurting my cardiac patients

The food industry is responding, at great speed, to a seed-oil narrative that is running well ahead of the evidence. Patients are paying the price.

By Cole Hanson


Check-in and intake at the doctor’s office are perfect for AI

The use of AI in clinical medicine in inevitable, so why not direct it to tasks such as the intake?

By Risa Jampel


STAT+ | Dark times ahead at the FDA

The leadership vacuum and chaos at the FDA is toxic to the agency getting its job done, writes STAT Lab Dish columnist Paul Knoepfler.

By Paul Knoepfler


An X-ray image shows a bullet fragment lodged in the hand of a gunshot victim.
COURTNEY BONNEAU/Middle East Images/AFP via Getty Images

Living with bullet fragments in the body can have long-term medical consequences

About 75% of firearm injury survivors live with retained bullet fragments. That can have long-term health consequences.

By Adeiyewunmi (Ade) Osinubi


I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside

Public attention during Ebola outbreaks often focuses on Western aid workers who become infected, ignoring the local health care workers.

By Krutika Kuppalli


The rise of perimenopause misinformation

On the ‘First Opinion Podcast,’ two experts discuss the rise of the perimenopause movement — and perimenopause misinformation.

By Torie Bosch


Jenny Kane/AP

Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it back

Banning tobacco sales to people born after a certain date is the most compassionate, strategic approach.

By Henry L. Dorkin and Katharine Silbaugh


I’m a heart transplant recipient. I’m haunted by ‘ghost approval’ for medication I need to survive

A heart transplant recipient writes that she is haunted by ‘ghost approval’ for medication she needs to survive.

By Payton Herres


‘Patient autonomy’ has nothing to do with childhood vaccine policies

While parents appropriately have broad rights and responsibilities for their children’s health, that is not "autonomy."

By Adam W. Gaffney


Adobe

How to restore credibility to the CDC’s vaccine advisory committee

Now is the time to prevent further disruption and confusion and to restore integrity to the ACIP and enhance public confidence, expert writes.

By Jesse L. Goodman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.